Loading...
SAT-475 New Breast Cancer Therapy Atezolizumab, Leads to Thyroiditis
Background: A NSABP B 59 trial is currently underway to check the efficacy of an experimental drug, Atezolizumab (Anti-PDL 1 monoclonal antibody) in the treatment of triple negative breast cancer. In the trail, the drug is added to the usual neoadjuvant chemotherapy given before surgery and prolonge...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7207941/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1074 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|